Patrick Bet-David explains why the FDA has officially approved CRISPR gene editing as a treatment for Sickle Cell Disease, marking a historic milestone in medical science. The science behind CRISPR-Cas9, a revolutionary gene-editing tool has transformed biomedical research. Understand how it can precisely alter DNA to correct genetic defects, potentially treating a range of illnesses. As CRISPR technology advances, so does the debate over its ethical use. PBD also discusses the controversial topic of designer babies, examining the moral implications and potential societal impacts of gene editing for non-therapeutic purposes.

Connect one-on-one with the right expert to get the answers you need with Minnect: https://bit.ly/3MC9IXE

Get best-in-class business advice with Bet-David Consulting: https://bit.ly/40oUafz

Visit VT.com for the latest news and insights from the world of politics, business and entertainment: https://bit.ly/472R3Mz

Visit Valuetainment University for the best courses online for entrepreneurs: https://bit.ly/47gKVA0

Text “PODCAST” to 310-340-1132 to get the latest updates in real-time!

SUBSCRIBE TO:
​⁠  @VALUETAINMENT 
 @PBDPodcast 
 @ValuetainmentShortClips 
 @vtsoscast 
 @VALUETAINMENTRUSSIAN 
 @ValuetainmentComedy 
 @bizdocpodcast 
 @BrandonAceto 
 @theunusualsuspectspodcast 
 @kvoncomedy 
​⁠
Want to be clear on your next 5 business moves? https://bit.ly/3Qzrj3m

Join the channel to get exclusive access to perks: https://bit.ly/3Q9rSQL

Download the podcasts on all your favorite platforms https://bit.ly/3sFAW4N

Patrick Bet-David is the founder and CEO of Valuetainment Media. He is the author of the #1 Wall Street Journal Bestseller “Your Next Five Moves” (Simon & Schuster) and a father of 2 boys and 2 girls. He currently resides in Ft. Lauderdale, Florida.

---

Support this podcast: https://podcasters.spotify.com/pod/show/valuetainment/support